Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-19-008596
Filing Date
2019-07-11
Accepted
2019-07-11 17:18:28
Documents
1
Period of Report
2019-07-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 4206
  Complete submission text file 0001179110-19-008596.txt   5664
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 215 FIRST STREET, SUITE 440 CAMBRIDGE MA 02142
Business Address
Horobin Joanna (Reporting) CIK: 0001560959 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 19951652